Krystal Biotech
KRYS
KRYS
113 hedge funds and large institutions have $1.27B invested in Krystal Biotech in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 53 increasing their positions, 29 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
45% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 11
5% more funds holding
Funds holding: 108 → 113 (+5)
3.62% more ownership
Funds ownership: 70.6% → 74.22% (+3.6%)
Holders
113
Holding in Top 10
3
Calls
$4.55M
Puts
$1.43M
Top Buyers
| 1 | +$97.9M | |
| 2 | +$29.7M | |
| 3 | +$20.2M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$12.1M |
| 5 |
JPMorgan Chase & Co
New York
|
+$11.2M |
Top Sellers
| 1 | -$25.5M | |
| 2 | -$6.06M | |
| 3 | -$5.04M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$4.24M |
| 5 |
Goldman Sachs
New York
|
-$2.53M |